A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection - Wikidata - wikimedia - TriplyDB

A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection

A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection

http://www.wikidata.org/entity/Q34582295

about

Crystal Structure of the Carbapenem Intrinsic Resistance Protein CarG Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins Phenotypic and molecular characterization of multidrug resistant Klebsiella pneumoniae isolated from a university teaching hospital, China Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae Antimicrobial activity of pomegranate fruit constituents against drug-resistant Mycobacterium tuberculosis and β-lactamase producing Klebsiella pneumoniae.Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting.Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae.Outcomes of an enhanced surveillance program for carbapenem-resistant Enterobacteriaceae Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infections Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens.Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs.Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates.A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.KlebSeq, a Diagnostic Tool for Surveillance, Detection, and Monitoring of Klebsiella pneumoniae Mortality markers in nosocomial Klebsiella pneumoniae bloodstream infection.Outcomes and Predictive Factors Associated with Adequacy of Antimicrobial Therapy in Patients with Central Line-Associated Bloodstream Infection.Klebsiella spp. in endoscopy-associated infections: we may only be seeing the tip of the iceberg.Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.Eravacycline for the treatment of intra-abdominal infections.Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.A hospital-based matched case-control study to identify risk factors for clinical infection with OXA-48-producing Klebsiella pneumoniae in rectal carriers.Carbapenemase-producing Enterobacteriaceae: Risk factors for infection and impact of resistance on outcomes.Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections.Chances and limitations of nanosized titanium dioxide practical application in view of its physicochemical properties.Risk factors of mortality in bloodstream infections caused by Klebsiella pneumonia: A single-center retrospective study in China.Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis.Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections.Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea.Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.Comparison of Infectious Agents Susceptibility to Photocatalytic Effects of Nanosized Titanium and Zinc Oxides: A Practical Approach Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections.Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.Polyphenolic Secondary Metabolites Synergize the Activity of Commercial Antibiotics against Clinical Isolates of β-Lactamase-producing Klebsiella pneumoniae.Carbapenem non-susceptibility of Klebsiella pneumoniae isolates in hospitals from 2011 to 2016, data from the German Antimicrobial Resistance Surveillance (ARS).

P2860

Q27681932-8A121A78-9E47-40A4-A136-C0FA3BAD5118 Q28067176-76671C44-836C-4DC9-B744-0E0EAE64F9A8 Q28537970-83B56B9A-26B9-4DAF-9574-8533A445E56C Q28548463-FDE4D647-FA59-445F-9540-19CD0A9C80A1 Q30235041-BBBBE0F9-CCDD-47D8-AF57-CF3443F678C8 Q30373540-60510A39-2AAA-4A1D-A6C7-2E2FA743E95B Q30457566-2F4517FB-0322-4EEB-8816-0C18E7FFE792 Q33630568-F2FFD340-DF03-4715-B90A-4FF4FBBE448E Q33798081-829287EE-C79D-4A4A-8493-F18F8529388C Q33821649-D0CFBA80-CCD8-4C0D-974C-128D1C9F82DB Q34298840-2E370E6E-4BB5-47CC-B376-7E75A86DEF48 Q34366895-F61FE99F-47DE-46D7-BD21-886C1F4E9ADF Q35005941-D5F6E154-08E6-49FC-86D0-C5F7FCE0A1CE Q36057355-B5C4108A-4F28-40C6-826A-7A3BC9511883 Q36181417-CBD1A108-0CA8-41F7-A4EC-F6E91311E7FD Q37280606-84798D9A-4A72-4A0D-83F0-23BF54C4A3DF Q37374197-5A7D5402-B0BA-4073-B9BA-E621B0D85B7E Q37528744-FDC12C33-66C9-4AC7-BBE4-799C2B79D48A Q38156049-EC54A0D3-25BD-4292-96EC-7E480588F6DB Q38228950-81C0206F-FF98-421C-9767-B12114B2C557 Q38253877-33362868-7672-40B8-8265-35E3D9BAF4F2 Q38672016-DA16BBBF-21C3-422E-ABEE-3065D7645862 Q38676987-4A1DD777-68E0-4998-A39C-52E0EAE8A22A Q38934524-81AE1FEB-B8CF-450F-8B56-9CD4B5946DA6 Q39037981-4D975586-9CC7-40F3-AFDC-AF3E0FC32EB6 Q39215563-4CE2B7C8-040B-4653-867D-442DB6AFC4C8 Q40072899-171A40FC-C03E-4411-A30F-BF5E3E13A9D9 Q40117270-2ABE0F70-1D53-4030-B125-8FDD7176F3C9 Q40494723-BD1B64D9-1CEA-42A3-BBF8-2E268B0EBBBA Q40530202-AB3752BF-C3E0-45A9-81C4-6B31632434AD Q40617815-265E99CA-5F85-49B4-A5A7-62620C5C392A Q41073810-A3DFB618-CD43-430F-A92F-472DD45EB319 Q41688964-3715C262-4B10-473A-9BFB-71C9659E6AD5 Q42216597-583EC644-AB61-4CBE-94AC-DF572AC30DD0 Q47313169-2DC7A7B7-2712-4566-B11B-FD0D9BC21F51 Q53805268-0C80E7D2-C345-4AD5-89A0-637A4C7BE05C Q55491430-799C6522-BC8E-4C0D-83EA-31EB9D6FEC33

P2860

A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection

http://www.wikidata.org/entity/Q34582295

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

A hospital-based matched case- ...... lebsiella pneumoniae infection

@ast

A hospital-based matched case- ...... lebsiella pneumoniae infection

@en

A hospital-based matched case- ...... lebsiella pneumoniae infection

@nl

type

label

A hospital-based matched case- ...... lebsiella pneumoniae infection

@ast

A hospital-based matched case- ...... lebsiella pneumoniae infection

@en

A hospital-based matched case- ...... lebsiella pneumoniae infection

@nl

prefLabel

A hospital-based matched case- ...... lebsiella pneumoniae infection

@ast

A hospital-based matched case- ...... lebsiella pneumoniae infection

@en

A hospital-based matched case- ...... lebsiella pneumoniae infection

@nl

P1433

Q34582295-AE92C730-48DB-4BAC-B3D1-AE0F80047A2B

P1476

Q34582295-056ABC73-8E6A-43C8-BE40-BD0292B2D9A4

P2093

Q34582295-1924F943-2B34-48D2-8B29-A22C68F9DF18

Q34582295-3C834257-EDC1-42A1-8FD2-3785C8292722

Q34582295-641B4AFA-C7DA-4FEA-9B40-A77808F84735

Q34582295-6CAD7386-9463-434E-A9CA-4747CDA1C2F5

Q34582295-B5AAA61E-80BD-4C7C-BB42-F74D7F99B0AF

Q34582295-BCBC5725-2081-4BD6-B676-58ADD325226A

Q34582295-CEE41ABB-2522-408E-B2FC-A906A9D1966B

Q34582295-D58E29DF-05EA-448E-AD5B-34CC0F5EA8ED

P2860

Q34582295-0F08FC4D-430E-40DE-9B7C-00D04687F89F

Q34582295-13FC4383-AAFC-4580-98E3-F8AD58A273EA

Q34582295-18BE9343-2D81-493B-B2A7-41BD12D49ACB

Q34582295-1FC248E3-1B0E-469F-BDDA-74634522BDB4

Q34582295-2566A991-5A9E-4CCB-9A69-C7E167D5D79F

Q34582295-2C55F0E4-326E-4752-9AD1-7AB0F81809AF

Q34582295-3960022F-96C5-47A1-9227-73C2135F5EE3

Q34582295-4C53B1F6-416F-4BA4-ACD8-EE881F23DD31

Q34582295-4EE6328C-DA0D-43FF-8CDB-AC562693478E

Q34582295-5A316084-E1D4-4B75-AA14-E7F649ECD7F2

P2888

Q34582295-7B09ED30-F266-412B-A5EE-55E0443179FD

P304

Q34582295-BCAAA3C4-C236-44F1-98F5-F2A08489724D

P31

Q34582295-FBF19A9B-FC90-419C-BD51-0ECB6B2E6A61

P356

Q34582295-D55335C4-3277-4D70-814E-1C62547B8E2A

P478

Q34582295-663F460B-F7C2-4908-9C47-C0A503F64E7E

P50

Q34582295-288230A4-75E0-4625-9740-A675985DC361

P577

Q34582295-0F34BBB2-AF22-4AD4-86E8-D0B337CB4668

P5875

Q34582295-3F86D0A9-12FD-4F46-AA89-B06C836D44D0

P6179

Q34582295-5A3D9DF6-00BB-4B3B-A5B2-C12344C1B010

P698

Q34582295-39001812-6B2D-48F5-9CB9-EEDBAFFDC9B1

P921

Q34582295-07CF756A-49B9-4407-A738-7A379E354B76

Q34582295-29A26FF9-C3B8-4E6D-BD80-A19605C7A4A6

P932

Q34582295-C60FB43F-E9C2-45B8-B8B7-128C37C09F2F

P356

1471-2334-13-80

P1433

BMC Infectious Diseases

P1476

A hospital-based matched case- ...... lebsiella pneumoniae infection

@en

P2093

Alexandre Rodrigues Marra

http://www.w3.org/2001/XMLSchema#string

Claudia Vallone Silva

http://www.w3.org/2001/XMLSchema#string

Itacy Siqueira

http://www.w3.org/2001/XMLSchema#string

Jacyr Pasternak

http://www.w3.org/2001/XMLSchema#string

Luci Correa

http://www.w3.org/2001/XMLSchema#string

Marines Dalla Valle Martino

http://www.w3.org/2001/XMLSchema#string

Patricia Faria Scherer

http://www.w3.org/2001/XMLSchema#string

Thiago Zinsly Sampaio Camargo

http://www.w3.org/2001/XMLSchema#string

P2860

Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

APACHE II: a severity of disease classification system

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia.

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes.

Hospital-acquired infections due to gram-negative bacteria.

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

P2888

1471-2334-13-80

P304

80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-13-80

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235520193

http://www.w3.org/2001/XMLSchema#string

P6179

1030377369

http://www.w3.org/2001/XMLSchema#string

P698

23398691

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

carbapenem antibiotic

P932

3574843

http://www.w3.org/2001/XMLSchema#string